Drugs / BLI-1300
last change Oct 2012 re-read 3 minutes ago

BLI-1300

Developed for
perianal Crohn disease
Investigated by
Braintree Laboratories

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01442363 Nov 2011 → Oct 2012 perianal Crohn disease Braintree Laboratories Terminated No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BLI-1300 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01442363 ↗
Route Topical “topical ointment” NCT01442363 ↗